bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Figure 5 from Chk2 Molecular Interaction Map and Rationale for Chk2 Inhibitors
Authors: Pommier Yves , Weinstein John N. , Aladjem Mirit I. , Kohn Kurt W.
Published: April 2023

Supplementary Figure 5 from Chk2 Molecular Interaction Map and Rationale for Chk2 Inhibitors
Supplementary Table S2 from Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution
Authors: Allred D. Craig , Wu Yun , Mao Sufeng , Nagtegaal Iris D. , Lee Sangjun , Perou Charles M. , Mohsin Syed K. , O'Connell Peter , Tsimelzon Anna , Medina Dan
Published: April 2023

Supplementary Table S2 from Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution
Supplementary Table S2 from Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers
Authors: Badoual Cécile , Hans Stéphane , Rodriguez José , Peyrard Severine , Klein Christophe , Agueznay Nour El Houda , Mosseri Véronique , Laccourreye Ollivier , Bruneval Patrick , Fridman Wolf H. , Brasnu Daniel F. , Tartour Eric
Published: April 2023

Supplementary Table S2 from Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers
Supplementary Table 1 from Induction of Interleukin-6 by Hepatitis C Virus Core Protein in Hepatitis C–Associated Mixed Cryoglobulinemia and B-Cell Non–Hodgkin's Lymphoma
Authors: Feldmann Georg , Nischalke Hans Dieter , Nattermann Jacob , Banas Brigitte , Berg Thomas , Teschendorf Christian , Schmiegel Wolff , Dührsen Ulrich , Halangk Juliane , Iwan Agathe , Sauerbruch Tilman , Caselmann Wolfgang H. , Spengler Ulrich
Published: April 2023

Supplementary Table 1 from Induction of Interleukin-6 by Hepatitis C Virus Core Protein in Hepatitis C–Associated Mixed Cryoglobulinemia and B-Cell Non–Hodgkin's Lymphoma
Supplementary Figure 1 from Hypoxia-Inducible Factor-1α and Hypoxia-Inducible Factor-2α Are Expressed in Kaposi Sarcoma and Modulated by Insulin-like Growth Factor-I
Authors: Catrina Sergiu-Bogdan , Botusan Ileana Ruxandra , Rantanen Anja , Catrina Anca Irinel , Pyakurel Pawan , Savu Octavian , Axelson Magnus , Biberfeld Peter , Poellinger Lorenz , Brismar Kerstin
Published: April 2023

Supplementary Figure 1 from Hypoxia-Inducible Factor-1α and Hypoxia-Inducible Factor-2α Are Expressed in Kaposi Sarcoma and Modulated by Insulin-like Growth Factor-I
Supplementary Table 1 from Differential Expression of Neuronal Genes Defines Subtypes of Disseminated Neuroblastoma with Favorable and Unfavorable Outcome
Authors: Fischer Matthias , Oberthuer André , Brors Benedikt , Kahlert Yvonne , Skowron Matthias , Voth Harald , Warnat Patrick , Ernestus Karen , Hero Barbara , Berthold Frank
Published: April 2023

Supplementary Table 1 from Differential Expression of Neuronal Genes Defines Subtypes of Disseminated Neuroblastoma with Favorable and Unfavorable Outcome
Supplementary Data from Gene Expression Profiling Reveals Potential Biomarkers of Human Hepatocellular Carcinoma
Authors: Jia Hu-Liang , Ye Qing-Hai , Qin Lun-Xiu , Budhu Anuradha , Forgues Marshonna , Chen Yidong , Liu Yin-Kun , Sun Hui-Chuan , Wang Lu , Lu Hong-Zhou , Shen Fang , Tang Zhao-You , Wang Xin Wei
Published: April 2023

Supplementary Materials and Methods, Figures, and Tables
Supplementary Table S8 from Transcriptional Profiling of Polycythemia Vera Identifies Gene Expression Patterns Both Dependent and Independent from the Action of JAK2V617F
Authors: Berkofsky-Fessler Windy , Buzzai Monica , Kim Marianne K-H. , Fruchtman Steven , Najfeld Vesna , Min Dong-Joon , Costa Fabricio F. , Bischof Jared M. , Soares Marcelo B. , McConnell Melanie Jane , Zhang Weijia , Levine Ross , Gilliland D. Gary , Calogero Raffaele , Licht Jonathan D.
Published: April 2023

Supplementary Table S8.
Related Article from Markers of Pancreatic Cancer: Working Toward Early Detection
Authors: Goggins Michael
Published: April 2023

Related Article from Markers of Pancreatic Cancer: Working Toward Early Detection
Supplementary Figures S1-S3 from Distinguishing Inflammation from Tumor and Peritumoral Edema by Myeloperoxidase Magnetic Resonance Imaging
Authors: Kleijn Anne , Chen John W. , Buhrman Jason S. , Wojtkiewicz Gregory R. , Iwamoto Yoshiko , Lamfers Martine L. , Stemmer-Rachamimov Anat O. , Rabkin Samuel D. , Weissleder Ralph , Martuza Robert L. , Fulci Giulia
Published: April 2023

Supplementary Figures S1-S3 from Distinguishing Inflammation from Tumor and Peritumoral Edema by Myeloperoxidase Magnetic Resonance Imaging
Supplementary Figure 2 Legend from Increased Expression of SIM2-s Protein Is a Novel Marker of Aggressive Prostate Cancer
Authors: Halvorsen Ole Johan , Rostad Kari , Øyan Anne Margrete , Puntervoll Hanne , Bø Trond Hellem , Stordrange Laila , Olsen Sue , Haukaas Svein Andreas , Hood Leroy , Jonassen Inge , Kalland Karl-Henning , Akslen Lars Andreas
Published: April 2023

Supplementary Figure 2 Legend from Increased Expression of SIM2-s Protein Is a Novel Marker of Aggressive Prostate Cancer
Supplementary Table from Gene Expression Differences Associated with Human Papillomavirus Status in Head and Neck Squamous Cell Carcinoma
Authors: Slebos Robbert J.C. , Yi Yajun , Ely Kim , Carter Jesse , Evjen Amy , Zhang Xueqiong , Shyr Yu , Murphy Barbara M. , Cmelak Anthony J. , Burkey Brian B. , Netterville James L. , Levy Shawn , Yarbrough Wendell G. , Chung Christine H.
Published: April 2023

Demographic and expression data
Supplementary Table 1 from Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer
Authors: Gure Ali O. , Chua Ramon , Williamson Barbara , Gonen Mithat , Ferrera Cathy A. , Gnjatic Sacha , Ritter Gerd , Simpson Andrew J.G. , Chen Yao-T. , Old Lloyd J. , Altorki Nasser K.
Published: April 2023

Gene specific PCR primers
Supplementary Figures S1-S7 from Urinary Glycoprotein Biomarker Discovery for Bladder Cancer Detection Using LC/MS-MS and Label-Free Quantification
Authors: Yang Na , Feng Shun , Shedden Kerby , Xie Xiaolei , Liu Yashu , Rosser Charles J. , Lubman David M. , Goodison Steven
Published: April 2023

Supplementary Figures S1-S7.
Supplementary Figure 2 from The p53 Pathway and Outcome among Patients with T1G3 Bladder Tumors
Authors: López-Knowles Elena , Hernández Silvia , Kogevinas Manolis , Lloreta Josep , Amorós Alex , Tardón Adonina , Carrato Alfredo , Kishore Sirish , Serra Consol , Malats Núria , Real Francisco X.
Published: April 2023

Supplementary Figure 2 from The p53 Pathway and Outcome among Patients with T1G3 Bladder Tumors
Supplementary Table 1 from An Innovative Microarray Strategy Identities Informative Molecular Markers for the Detection of Micrometastatic Breast Cancer
Authors: Mikhitarian Kaidi , Gillanders William E. , Almeida Jonas S. , Hebert Martin Renee , Varela Juan C. , Metcalf John S. , Cole David J. , Mitas Michael
Published: April 2023

Supplementary Table 1 from An Innovative Microarray Strategy Identities Informative Molecular Markers for the Detection of Micrometastatic Breast Cancer
Supplementary Table 3 from Gene Expression Signatures for Tumor Progression, Tumor Subtype, and Tumor Thickness in Laser-Microdissected Melanoma Tissues
Authors: Jaeger Jochen , Koczan Dirk , Thiesen Hans-Juergen , Ibrahim Saleh M. , Gross Gerd , Spang Rainer , Kunz Manfred
Published: April 2023

Supplementary Table 3 from Gene Expression Signatures for Tumor Progression, Tumor Subtype, and Tumor Thickness in Laser-Microdissected Melanoma Tissues
Supplementary Figure 1 from Gene Expression Signatures for Tumor Progression, Tumor Subtype, and Tumor Thickness in Laser-Microdissected Melanoma Tissues
Authors: Jaeger Jochen , Koczan Dirk , Thiesen Hans-Juergen , Ibrahim Saleh M. , Gross Gerd , Spang Rainer , Kunz Manfred
Published: April 2023

Supplementary Figure 1 from Gene Expression Signatures for Tumor Progression, Tumor Subtype, and Tumor Thickness in Laser-Microdissected Melanoma Tissues
Supplementary Methods 4 from Systematic CpG Islands Methylation Profiling of Genes in the Wnt Pathway in Epithelial Ovarian Cancer Identifies Biomarkers of Progression-Free Survival
Authors: Dai Wei , Teodoridis Jens M. , Zeller Constanze , Graham Janet , Hersey Jenny , Flanagan James M. , Stronach Euan , Millan David W. , Siddiqui Nadeem , Paul Jim , Brown Robert
Published: April 2023

Supplementary Methods 4 from Systematic CpG Islands Methylation Profiling of Genes in the Wnt Pathway in Epithelial Ovarian Cancer Identifies Biomarkers of Progression-Free Survival
Supplementary Data from Molecular Classification of Gastric Cancer: A New Paradigm
Authors: Shah Manish A. , Khanin Raya , Tang Laura , Janjigian Yelena Y. , Klimstra David S. , Gerdes Hans , Kelsen David P.
Published: April 2023

Supplementary Figure S1; Supplementary Table S1.
Supplementary Methods 3 from Systematic CpG Islands Methylation Profiling of Genes in the Wnt Pathway in Epithelial Ovarian Cancer Identifies Biomarkers of Progression-Free Survival
Authors: Dai Wei , Teodoridis Jens M. , Zeller Constanze , Graham Janet , Hersey Jenny , Flanagan James M. , Stronach Euan , Millan David W. , Siddiqui Nadeem , Paul Jim , Brown Robert
Published: April 2023

Supplementary Methods 3 from Systematic CpG Islands Methylation Profiling of Genes in the Wnt Pathway in Epithelial Ovarian Cancer Identifies Biomarkers of Progression-Free Survival
Supplementary Tables 1-4 from Gene Expression Profiling in Cervical Cancer: An Exploration of Intratumor Heterogeneity
Authors: Bachtiary Barbara , Boutros Paul C. , Pintilie Melania , Shi Willa , Bastianutto Carlo , Li Jian-Hua , Schwock Joerg , Zhang Wendy , Penn Linda Z. , Jurisica Igor , Fyles Anthony , Liu Fei-Fei
Published: April 2023

Supplementary Tables 1-4 from Gene Expression Profiling in Cervical Cancer: An Exploration of Intratumor Heterogeneity
Supplementary Figure Legends 1-3 from Gene Expression Profiling in Cervical Cancer: An Exploration of Intratumor Heterogeneity
Authors: Bachtiary Barbara , Boutros Paul C. , Pintilie Melania , Shi Willa , Bastianutto Carlo , Li Jian-Hua , Schwock Joerg , Zhang Wendy , Penn Linda Z. , Jurisica Igor , Fyles Anthony , Liu Fei-Fei
Published: April 2023

Supplementary Figure Legends 1-3 from Gene Expression Profiling in Cervical Cancer: An Exploration of Intratumor Heterogeneity
Supplementary Table 1 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Authors: Okano Tetsuya , Kondo Tadashi , Fujii Kiyonaga , Nishimura Toshihide , Takano Toshimi , Ohe Yuichiro , Tsuta Koji , Matsuno Yoshihiro , Gemma Akihiko , Kato Harbumi , Kudoh Shoji , Hirohashi Setsuo
Published: April 2023

Supplementary Table 1 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Supplementary Figure 7 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Authors: Okano Tetsuya , Kondo Tadashi , Fujii Kiyonaga , Nishimura Toshihide , Takano Toshimi , Ohe Yuichiro , Tsuta Koji , Matsuno Yoshihiro , Gemma Akihiko , Kato Harbumi , Kudoh Shoji , Hirohashi Setsuo
Published: April 2023

Supplementary Figure 7 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Supplementary Figure S1 from c-Met Is a Potentially New Therapeutic Target for Treatment of Human Melanoma
Authors: Puri Neelu , Ahmed Salman , Janamanchi Varalakshmi , Tretiakova Maria , Zumba Osvaldo , Krausz Thomas , Jagadeeswaran Ramasamy , Salgia Ravi
Published: April 2023

Supplementary Figure S1 from c-Met Is a Potentially New Therapeutic Target for Treatment of Human Melanoma
Supplementary Figure 3 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Authors: Okano Tetsuya , Kondo Tadashi , Fujii Kiyonaga , Nishimura Toshihide , Takano Toshimi , Ohe Yuichiro , Tsuta Koji , Matsuno Yoshihiro , Gemma Akihiko , Kato Harbumi , Kudoh Shoji , Hirohashi Setsuo
Published: April 2023

Supplementary Figure 3 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Supplementary Data from Induction of B-Chronic Lymphocytic Leukemia Cell Apoptosis by Arsenic Trioxide Involves Suppression of the Phosphoinositide 3-Kinase/Akt Survival Pathway via c-jun-NH2 Terminal Kinase Activation and PTEN Upregulation
Authors: Redondo-Muñoz Javier , Escobar-Díaz Elizabeth , Hernández del Cerro Mercedes , Pandiella Atanasio , Terol María José , García-Marco José A. , García-Pardo Angeles
Published: April 2023

Supplementary Data from Induction of B-Chronic Lymphocytic Leukemia Cell Apoptosis by Arsenic Trioxide Involves Suppression of the Phosphoinositide 3-Kinase/Akt Survival Pathway via c-jun-NH2 Terminal Kinase Activation and PTEN Upregulation
CCR Translation for This Article from Induction of B-Chronic Lymphocytic Leukemia Cell Apoptosis by Arsenic Trioxide Involves Suppression of the Phosphoinositide 3-Kinase/Akt Survival Pathway via c-jun-NH2 Terminal Kinase Activation and PTEN Upregulation
Authors: Redondo-Muñoz Javier , Escobar-Díaz Elizabeth , Hernández del Cerro Mercedes , Pandiella Atanasio , Terol María José , García-Marco José A. , García-Pardo Angeles
Published: April 2023

CCR Translation for This Article from Induction of B-Chronic Lymphocytic Leukemia Cell Apoptosis by Arsenic Trioxide Involves Suppression of the Phosphoinositide 3-Kinase/Akt Survival Pathway via c-jun-NH2 Terminal Kinase Activation and PTEN Upregulation
Supplementary Table S1 from Accelerated Preclinical Testing Using Transplanted Tumors from Genetically Engineered Mouse Breast Cancer Models
Authors: Varticovski Lyuba , Hollingshead Melinda G. , Robles Ana I. , Wu Xiaolin , Cherry James , Munroe David J. , Lukes Luanne , Anver Miriam R. , Carter John P. , Borgel Suzanne D. , Stotler Howard , Bonomi Carrie A. , Nunez Nomelí P. , Hursting Stephen D. , Qiao Wenhui , Deng Chuxia X. , Green Jeff E. , Hunter Kent W. , Merlino Glenn , Steeg Patricia S. , Wakefield Lalage M. , Barrett J. Carl
Published: April 2023

Supplementary Table S1 from Accelerated Preclinical Testing Using Transplanted Tumors from Genetically Engineered Mouse Breast Cancer Models
Supplementary Data from Phase I Studies of CBP501, a G2 Checkpoint Abrogator, as Monotherapy and in Combination with Cisplatin in Patients with Advanced Solid Tumors
Authors: Shapiro Geoffrey I. , Tibes Raoul , Gordon Michael S. , Wong Bryan Y. , Eder Joseph Paul , Borad Mitesh J. , Mendelson David S. , Vogelzang Nicholas J. , Bastos Bruno R. , Weiss Glen J. , Fernandez Cristian , Sutherland William , Sato Hitoshi , Pierceall William E. , Weaver David , Slough Scott , Wasserman Ernesto , Kufe Donald W. , Von Hoff Daniel , Kawabe Takumi , Sharma Sunil
Published: April 2023

Supplementary Figure S1; Supplementary Tables S1-S2.
Supplementary Data from Heterogeneity of Breast Cancer Metastases: Comparison of Therapeutic Target Expression and Promoter Methylation Between Primary Tumors and Their Multifocal Metastases
Authors: Wu Julie M. , Fackler Mary Jo , Halushka Marc K. , Molavi Diana W. , Taylor M. Evangeline , Teo Wei Wen , Griffin Constance , Fetting John , Davidson Nancy E. , De Marzo Angelo M. , Hicks Jessica L. , Chitale Dhananjay , Ladanyi Marc , Sukumar Saraswati , Argani Pedram
Published: April 2023

Supplementary Data from Heterogeneity of Breast Cancer Metastases: Comparison of Therapeutic Target Expression and Promoter Methylation Between Primary Tumors and Their Multifocal Metastases
Supplementary Figures 1-4 from Engineering the Brain Tumor Microenvironment Enhances the Efficacy of Dendritic Cell Vaccination: Implications for Clinical Trial Design
Authors: Mineharu Yohei , King Gwendalyn D. , Muhammad AKM G. , Bannykh Serguei , Kroeger Kurt M. , Liu Chunyan , Lowenstein Pedro R. , Castro Maria G.
Published: April 2023

Supplementary Figures 1-4 from Engineering the Brain Tumor Microenvironment Enhances the Efficacy of Dendritic Cell Vaccination: Implications for Clinical Trial Design
Supplementary Figure 2 from Killing of Chronic Lymphocytic Leukemia by the Combination of Fludarabine and Oxaliplatin Is Dependent on the Activity of XPF Endonuclease
Authors: Zecevic Alma , Sampath Deepa , Ewald Brett , Chen Rong , Wierda William , Plunkett William
Published: April 2023

Supplementary Figure 2 from Killing of Chronic Lymphocytic Leukemia by the Combination of Fludarabine and Oxaliplatin Is Dependent on the Activity of XPF Endonuclease
Supplemental Figures from Glycogen Synthase Kinase-3β: A Prognostic Marker and a Potential Therapeutic Target in Human Bladder Cancer
Authors: Naito Sei , Bilim Vladimir , Yuuki Kaori , Ugolkov Andrey , Motoyama Teiichi , Nagaoka Akira , Kato Tomoyuki , Tomita Yoshihiko
Published: April 2023

Supplemental Figure 1. Immunohistochemical staining of GSK-3β in low (A-C) and high (D-F) grade urothelial tumors. Supplemental Figure 2. Hoechst staining of T24 cancer cells treated with 3 distinct small molecule inhibitors of GSK-3 (AR-A014418, SB-415286, and TDZD-8). The arrows point at apoptotic cells. The percentage of apoptotic cells is shown as indicated on each picture. Supplemental Figure 3. HT1376 and T24 cancer cells were treated with indicated doses of AR-A014418; 48, 72 and 96 h after treatment, cell lysates were separated by SDS-PAGE, transferred to PVDF membrane and probed with antibodies to indicated proteins.
Supplementary Data from Genetic Aberrations Leading to MAPK Pathway Activation Mediate Oncogene-Induced Senescence in Sporadic Pilocytic Astrocytomas
Authors: Jacob Karine , Quang-Khuong Dongh-Anh , Jones David T.W. , Witt Hendrik , Lambert Sally , Albrecht Steffen , Witt Olaf , Vezina Catherine , Shirinian Margret , Faury Damien , Garami Miklos , Hauser Peter , Klekner Almos , Bognar Laszlo , Farmer Jean-Pierre , Montes Jose-Luis , Atkinson Jeffrey , Hawkins Cynthia , Korshunov Andrey , Collins V. Peter , Pfister Stefan M. , Tabori Uri , Jabado Nada
Published: April 2023

Supplementary Figures S1-S3; Supplementary Tables S1-S2.
Related Article from HER2 Fragmentation and Breast Cancer Stratification
Authors: Arribas Joaquín , Parra-Palau Josep Lluís , Pedersen Kim
Published: April 2023

Related Article from HER2 Fragmentation and Breast Cancer Stratification
CCR Translation for This Article from Randomized Double-Blind Trial of Sulindac and Etodolac to Eradicate Aberrant Crypt Foci and to Prevent Sporadic Colorectal Polyps
Authors: Takayama Tetsuji , Nagashima Hiroyuki , Maeda Masahiro , Nojiri Shuichi , Hirayama Michiaki , Nakano Yoichiro , Takahashi Yasuo , Sato Yasushi , Sekikawa Hitoshi , Mori Mitsuru , Sonoda Tomoko , Kimura Tetsuo , Kato Junji , Niitsu Yoshiro
Published: April 2023

CCR Translation for This Article from Randomized Double-Blind Trial of Sulindac and Etodolac to Eradicate Aberrant Crypt Foci and to Prevent Sporadic Colorectal Polyps
Supplementary Data from Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients
Authors: Besser Michal J. , Shapira-Frommer Ronnie , Treves Avraham J. , Zippel Dov , Itzhaki Orit , Hershkovitz Liat , Levy Daphna , Kubi Adva , Hovav Einat , Chermoshniuk Natalia , Shalmon Bruria , Hardan Izhar , Catane Raphael , Markel Gal , Apter Sara , Ben-Nun Alon , Kuchuk Iryna , Shimoni Avichai , Nagler Arnon , Schachter Jacob
Published: April 2023

Supplementary Data from Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients
Supplementary Figure 5 from MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells
Authors: Bridges Kathleen A. , Hirai Hiroshi , Buser Carolyn A. , Brooks Colin , Liu Huifeng , Buchholz Thomas A. , Molkentine Jessica M. , Mason Kathryn A. , Meyn Raymond E.
Published: April 2023

PDF file - 16.5 MB
Supplementary Data from T-Cell Receptor Gene–Modified T Cells with Shared Renal Cell Carcinoma Specificity for Adoptive T-Cell Therapy
Authors: Leisegang Matthias , Turqueti-Neves Adriana , Engels Boris , Blankenstein Thomas , Schendel Dolores J. , Uckert Wolfgang , Noessner Elfriede
Published: April 2023

Supplementary Data from T-Cell Receptor Gene–Modified T Cells with Shared Renal Cell Carcinoma Specificity for Adoptive T-Cell Therapy
Supplementary Table S1 from IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer
Authors: Anglesio Michael S. , George Joshy , Kulbe Hagen , Friedlander Michael , Rischin Danny , Lemech Charlotte , Power Jeremy , Coward Jermaine , Cowin Prue A. , House Colin M. , Chakravarty Probir , Gorringe Kylie L. , Campbell Ian G. , Okamoto Aikou , Birrer Michael J. , Huntsman David G. , de Fazio Anna , Kalloger Steve E. , Balkwill Frances , Gilks C. Blake , Bowtell David D.
Published: April 2023

Supplementary Table S1.
Supplementary Figures S1-S5 from IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer
Authors: Anglesio Michael S. , George Joshy , Kulbe Hagen , Friedlander Michael , Rischin Danny , Lemech Charlotte , Power Jeremy , Coward Jermaine , Cowin Prue A. , House Colin M. , Chakravarty Probir , Gorringe Kylie L. , Campbell Ian G. , Okamoto Aikou , Birrer Michael J. , Huntsman David G. , de Fazio Anna , Kalloger Steve E. , Balkwill Frances , Gilks C. Blake , Bowtell David D.
Published: April 2023

Supplementary Figures S1-S5.
Supplementary Figure 5 from Cell Surface Delivery of TRAIL Strongly Augments the Tumoricidal Activity of T Cells
Authors: de Bruyn Marco , Wei Yunwei , Wiersma Valerie R. , Samplonius Douwe F. , Klip Harry G. , van der Zee Ate G.J. , Yang Baofeng , Helfrich Wijnand , Bremer Edwin
Published: April 2023

PDF file - 88K
Supplementary Data from Quercetin Induces Tumor-Selective Apoptosis through Downregulation of Mcl-1 and Activation of Bax
Authors: Cheng Senping , Gao Ning , Zhang Zhuo , Chen Gang , Budhraja Amit , Ke Zunji , Son Young-ok , Wang Xin , Luo Jia , Shi Xianglin
Published: April 2023

Supplementary Figures S1-S3 and Supplementary Materials and Methods.
Supplementary Table S3 from Gene Signatures for the Prediction of Response to Bacillus Calmette-Guérin Immunotherapy in Primary pT1 Bladder Cancers
Authors: Kim Yong-June , Ha Yun-Sok , Kim Seon-Kyu , Yoon Hyung Yoon , Lym Min Su , Kim Min-Ju , Moon Sung-Kwon , Choi Yung Hyun , Kim Wun-Jae
Published: April 2023

Supplementary Table S3 from Gene Signatures for the Prediction of Response to Bacillus Calmette-Guérin Immunotherapy in Primary pT1 Bladder Cancers
Supplementary Data from Targeting Galectin-1 in Carcinoma-Associated Fibroblasts Inhibits Oral Squamous Cell Carcinoma Metastasis by Downregulating MCP-1/CCL2 Expression
Authors: Wu Ming-Heng , Hong Hsiao-Chin , Hong Tse-Ming , Chiang Wei-Fan , Jin Ying-Tai , Chen Yuh-Ling
Published: April 2023

Supplementary Figures S1-S6; Supplementary Table S1.
Related Article from Imaging Breast Cancer Chemotherapy Response with Light
Authors: Tromberg Bruce J. , Cerussi Albert E.
Published: April 2023

Related Article from Imaging Breast Cancer Chemotherapy Response with Light
Supplementary Methods, Figure Legends 1-3 from PRAME-Specific Allo-HLA–Restricted T Cells with Potent Antitumor Reactivity Useful for Therapeutic T-Cell Receptor Gene Transfer
Authors: Amir Avital L. , van der Steen Dirk M. , van Loenen Marleen M. , Hagedoorn Renate S. , de Boer Renate , Kester Michel D.G. , de Ru Arnoud H. , Lugthart Gert-Jan , van Kooten Cees , Hiemstra Pieter S. , Jedema Inge , Griffioen Marieke , van Veelen Peter A. , Falkenburg J.H. Frederik , Heemskerk Mirjam H.M.
Published: April 2023

PDF file - 77K
Supplementary Data from Phase II, Open-Label Study of Brivanib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
Authors: Park Joong-Won , Finn Richard S. , Kim Jun Suk , Karwal Mark , Li Ruby K. , Ismail Fuad , Thomas Melanie , Harris Rosemarie , Baudelet Christine , Walters Ian , Raoul Jean-Luc
Published: April 2023

Supplementary Data; Supplementary Tables S1-S2.
Supplementary Table 2 from Intrinsic Breast Tumor Subtypes, Race, and Long-Term Survival in the Carolina Breast Cancer Study
Authors: O'Brien Katie M. , Cole Stephen R. , Tse Chiu-Kit , Perou Charles M. , Carey Lisa A. , Foulkes William D. , Dressler Lynn G. , Geradts Joseph , Millikan Robert C.
Published: April 2023

PDF file - 8K
Supplementary Data from Acquisition of Chemoresistance and EMT Phenotype Is Linked with Activation of the Endothelin A Receptor Pathway in Ovarian Carcinoma Cells
Authors: Rosanò Laura , Cianfrocca Roberta , Spinella Francesca , Di Castro Valeriana , Nicotra Maria Rita , Lucidi Alessandro , Ferrandina Gabriella , Natali Pier Giorgio , Bagnato Anna
Published: April 2023

Supplementary Figures S1-S3; Supplementary Methods.
Supplementary Data from A Novel Oncolytic Herpes Simplex Virus that Synergizes with Phosphoinositide 3-kinase/Akt Pathway Inhibitors to Target Glioblastoma Stem Cells
Authors: Kanai Ryuichi , Wakimoto Hiroaki , Martuza Robert L. , Rabkin Samuel D.
Published: April 2023

Supplementary Figures S1-S7; Supplementary Table S1.
Supplementary Figure S1 from Bortezomib Enhances the Efficacy of Fulvestrant by Amplifying the Aggregation of the Estrogen Receptor, Which Leads to a Proapoptotic Unfolded Protein Response
Authors: Ishii Yuki , Papa Luena , Bahadur Urvashi , Yue Zhenyu , Aguirre-Ghiso Julio , Shioda Toshi , Waxman Samuel , Germain Doris
Published: April 2023

Supplementary Figure S1.
Supplementary Figure 4 from Clinical Effects of Adjuvant Active Specific Immunotherapy Differ between Patients with Microsatellite-Stable and Microsatellite-Instable Colon Cancer
Authors: de Weger Vincent A. , Turksma Annelies W. , Voorham Quirinus J.M. , Euler Zelda , Bril Herman , van den Eertwegh Alfons J. , Bloemena Elisabeth , Pinedo Herbert M. , Vermorken Jan B. , van Tinteren Harm , Meijer Gerrit A. , Hooijberg Erik
Published: April 2023

PDF file - 79K
Supplementary Figure 1 from Enhanced Antitumor Efficacy of Low-Dose Etoposide with Oncolytic Herpes Simplex Virus in Human Glioblastoma Stem Cell Xenografts
Authors: Cheema Tooba A. , Kanai Ryuichi , Kim Geon Woo , Wakimoto Hiroaki , Passer Brent , Rabkin Samuel D. , Martuza Robert L.
Published: April 2023

PDF file - 198KB
Supplementary Figure 4 from The Prognostic Significance of Various 13q14 Deletions in Chronic Lymphocytic Leukemia
Authors: Ouillette Peter , Collins Roxane , Shakhan Sajid , Li Jinghui , Li Cheng , Shedden Kerby , Malek Sami N.
Published: April 2023

PDF file - 330KB
Supplementary Figure 2 from A Hypermethylated Phenotype Is a Better Predictor of Survival than MGMT Methylation in Anaplastic Oligodendroglial Brain Tumors: A Report from EORTC Study 26951
Authors: van den Bent Martin J. , Gravendeel Lonneke A. , Gorlia Thierry , Kros Johan M. , Lapre Lariesa , Wesseling Pieter , Teepen Johannes L. , Idbaih Ahmed , Sanson Marc , Smitt Peter A.E. Sillevis , French Pim J.
Published: April 2023

PDF file - 256KB
Supplementary Figure 2 from Molecular Imaging of TGFβ-Induced Smad2/3 Phosphorylation Reveals a Role for Receptor Tyrosine Kinases in Modulating TGFβ Signaling
Authors: Nyati Shyam , Schinske Katrina , Ray Dipankar , Nyati Mukesh , Ross Brian Dale , Rehemtulla Alnawaz
Published: April 2023

PDF file - 115K
Supplementary Table 3 from Effective Targeting of Triple-Negative Breast Cancer Cells by PF-4942847, a Novel Oral Inhibitor of Hsp 90
Authors: Mehta Pramod P. , Whalen Pamela , Baxi Sangita M. , Kung Pei-Pei , Yamazaki Shinji , Yin Min-Jean
Published: April 2023

XLS file - 76K
Supplementary Table 4 from Reduced miR-128 in Breast Tumor–Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5
Authors: Zhu Yinghua , Yu Fengyan , Jiao Yu , Feng Juan , Tang Wei , Yao Herui , Gong Chang , Chen Jianing , Su Fengxi , Zhang Yan , Song Erwei
Published: April 2023

PDF file - 63K
Supplementary Figure Legend 1 from Molecular Analysis of Colorectal Tumors within a Diverse Patient Cohort at a Single Institution
Authors: Sylvester Brooke E. , Huo Dezheng , Khramtsov Andrey , Zhang Jing , Smalling Rana V. , Olugbile Sope , Polite Blase N. , Olopade Olufunmilayo I.
Published: April 2023

PDF file - 60K
Supplementary Figure Legend from FGFR4 Blockade Exerts Distinct Antitumorigenic Effects in Human Embryonal versus Alveolar Rhabdomyosarcoma
Authors: Crose Lisa E.S. , Etheridge Katherine T. , Chen Candy , Belyea Brian , Talbot Lindsay J. , Bentley Rex C. , Linardic Corinne M.
Published: April 2023

PDF file, 78KB.
Supplementary Data from Vandetanib Improves Anti-Tumor Effects of L19mTNFα in Xenograft Models of Esophageal Cancer
Authors: Crescenzi Marika , Persano Luca , Esposito Giovanni , Zulato Elisabetta , Borsi Laura , Balza Enrica , Ruol Alberto , Ancona Ermanno , Indraccolo Stefano , Amadori Alberto
Published: April 2023

Supplementary Figures S1-S6; Supplementary Table S1.
Supplementary Figure 2 from FGFR4 Blockade Exerts Distinct Antitumorigenic Effects in Human Embryonal versus Alveolar Rhabdomyosarcoma
Authors: Crose Lisa E.S. , Etheridge Katherine T. , Chen Candy , Belyea Brian , Talbot Lindsay J. , Bentley Rex C. , Linardic Corinne M.
Published: April 2023

PDF file, 694KB, FGFR4 levels correlate with cell growth in HSMM cells.
Supplementary Figure 1 from FGFR4 Blockade Exerts Distinct Antitumorigenic Effects in Human Embryonal versus Alveolar Rhabdomyosarcoma
Authors: Crose Lisa E.S. , Etheridge Katherine T. , Chen Candy , Belyea Brian , Talbot Lindsay J. , Bentley Rex C. , Linardic Corinne M.
Published: April 2023

PDF file, 478KB, Suppression of FGFR4 in RD cells reduces cell proliferation in culture.
Supplementary Table 5 from Antitumor Activity of Sustained N-Myc Reduction in Rhabdomyosarcomas and Transcriptional Block by Antigene Therapy
Authors: Tonelli Roberto , McIntyre Alan , Camerin Consuelo , Walters Zoë S. , Di Leo Korinne , Selfe Joanna , Purgato Stefania , Missiaglia Edoardo , Tortori Andrea , Renshaw Jane , Astolfi Annalisa , Taylor Kathryn R. , Serravalle Salvatore , Bishop Ryan , Nanni Cristina , Valentijn Linda J. , Faccini Andrea , Leuschner Ivo , Formica Serena , Reis-Filho Jorge S. , Ambrosini Valentina , Thway Khin , Franzoni Monica , Summersgill Brenda , Marchelli Rosangela , Hrelia Patrizia , Cantelli-Forti Giorgio , Fanti Stefano , Corradini Roberto , Pession Andrea , Shipley Janet
Published: April 2023

PDF file - 104K
Supplementary Materials and Methods from Antitumor Activity of Sustained N-Myc Reduction in Rhabdomyosarcomas and Transcriptional Block by Antigene Therapy
Authors: Tonelli Roberto , McIntyre Alan , Camerin Consuelo , Walters Zoë S. , Di Leo Korinne , Selfe Joanna , Purgato Stefania , Missiaglia Edoardo , Tortori Andrea , Renshaw Jane , Astolfi Annalisa , Taylor Kathryn R. , Serravalle Salvatore , Bishop Ryan , Nanni Cristina , Valentijn Linda J. , Faccini Andrea , Leuschner Ivo , Formica Serena , Reis-Filho Jorge S. , Ambrosini Valentina , Thway Khin , Franzoni Monica , Summersgill Brenda , Marchelli Rosangela , Hrelia Patrizia , Cantelli-Forti Giorgio , Fanti Stefano , Corradini Roberto , Pession Andrea , Shipley Janet
Published: April 2023

PDF file - 135K
Supplementary Table 3 from Predictive Value of XRCC1 Gene Polymorphisms on Platinum-Based Chemotherapy in Advanced Non–Small Cell Lung Cancer Patients: A Systematic Review and Meta-analysis
Authors: Wu Junjie , Liu Jie , Zhou Yuhao , Ying Jun , Zou Houdong , Guo Shicheng , Wang Lei , Zhao Naiqing , Hu Jianjun , Lu Daru , Jin Li , Li Qiang , Wang Jiu-Cun
Published: April 2023

XLSX file, 12KB, Random effects HR with the corresponding 95% CI and heterogeneity results for multiple pairwise comparisons of XRCC1Gln399Arg and 5-year survival to chemotherapy.
Supplementary Figure 2 from BARD1 Expression Predicts Outcome in Colon Cancer
Authors: Sporn Judith C. , Hothorn Torsten , Jung Barbara
Published: April 2023

PDF file - 350K
CCR Translation for This Article from MicroRNA-10b Expression Correlates with Response to Neoadjuvant Therapy and Survival in Pancreatic Ductal Adenocarcinoma
Authors: Preis Meir , Gardner Timothy B. , Gordon Stuart R. , Pipas J. Marc , Mackenzie Todd A. , Klein Erin E. , Longnecker Daniel S. , Gutmann Edward J. , Sempere Lorenzo F. , Korc Murray
Published: April 2023

CCR Translation for This Article from MicroRNA-10b Expression Correlates with Response to Neoadjuvant Therapy and Survival in Pancreatic Ductal Adenocarcinoma
Supplementary Figure Legends 1-2 from Phase I Study of the Combination of Sorafenib and Temsirolimus in Patients with Metastatic Melanoma
Authors: Davies Michael A. , Fox Patricia S. , Papadopoulos Nicholas E. , Bedikian Agop Y. , Hwu Wen-Jen , Lazar Alexander J. , Prieto Victor G. , Culotta Kirk S. , Madden Timothy L. , Xu Quanyun , Huang Sha , Deng Wanleng , Ng Chaan S. , Gupta Sanjay , Liu Wenbin , Dancey Janet E. , Wright John J. , Bassett Roland L. , Hwu Patrick , Kim Kevin B.
Published: April 2023

PDF file - 85K
Supplementary Table 1 from Histone Deacetylase Inhibitors Induce Growth Arrest and Differentiation in Uveal Melanoma
Authors: Landreville Solange , Agapova Olga A. , Matatall Katie A. , Kneass Zachary T. , Onken Michael D. , Lee Ryan S. , Bowcock Anne M. , Harbour J. William
Published: April 2023

PDF file - 17K
Supplementary Table 3 from Regulation of CD20 in Rituximab-Resistant Cell Lines and B-cell Non-Hodgkin Lymphoma
Authors: Tsai Ping-Chiao , Hernandez-Ilizaliturri Francisco J. , Bangia Naveen , Olejniczak Scott H. , Czuczman Myron S.
Published: April 2023

PDF file - 43K
Supplementary Figure 2 from Vandetanib, an Inhibitor of VEGF Receptor-2 and EGF Receptor, Suppresses Tumor Development and Improves Prognosis of Liver Cancer in Mice
Authors: Inoue Kinya , Torimura Takuji , Nakamura Toru , Iwamoto Hideki , Masuda Hiroshi , Abe Mitsuhiko , Hashimoto Osamu , Koga Hironori , Ueno Takato , Yano Hirohisa , Sata Michio
Published: April 2023

PDF file, 82KB, Inhibitory effect of vandetanib on phosphorylation of EGFR.
Supplementary Figure 6 from Downregulation of SMG-1 in HPV-Positive Head and Neck Squamous Cell Carcinoma Due to Promoter Hypermethylation Correlates with Improved Survival
Authors: Gubanova Evgenia , Brown Brandee , Ivanov Sergei V. , Helleday Thomas , Mills Gordon B. , Yarbrough Wendell G. , Issaeva Natalia
Published: April 2023

PDF file - 320K
Supplementary Figures 1-6 from Correlation of ERG Expression and DNA Methylation Biomarkers with Adverse Clinicopathologic Features of Prostate Cancer
Authors: Kron Ken , Liu Liyang , Trudel Dominique , Pethe Vaijayanti , Trachtenberg John , Fleshner Neil , Bapat Bharati , van der Kwast Theodorus
Published: April 2023

PDF file, 282KB.
Supplementary Figures 1-8 from Therapeutic Implications for the Induced Levels of Chk1 in Myc-Expressing Cancer Cells
Authors: Höglund Andreas , Nilsson Lisa M. , Muralidharan Somsundar Veppil , Hasvold Lisa A. , Merta Philip , Rudelius Martina , Nikolova Viktoriya , Keller Ulrich , Nilsson Jonas A.
Published: April 2023

PDF file - 1.2MB
Supplementary Figure 7 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway
Authors: Yoshihara Kosuke , Tsunoda Tatsuhiko , Shigemizu Daichi , Fujiwara Hiroyuki , Hatae Masayuki , Fujiwara Hisaya , Masuzaki Hideaki , Katabuchi Hidetaka , Kawakami Yosuke , Okamoto Aikou , Nogawa Takayoshi , Matsumura Noriomi , Udagawa Yasuhiro , Saito Tsuyoshi , Itamochi Hiroaki , Takano Masashi , Miyagi Etsuko , Sudo Tamotsu , Ushijima Kimio , Iwase Haruko , Seki Hiroyuki , Terao Yasuhisa , Enomoto Takayuki , Mikami Mikio , Akazawa Kohei , Tsuda Hitoshi , Moriya Takuya , Tajima Atsushi , Inoue Ituro , Tanaka Kenichi
Published: April 2023

PDF file - 435K
Supplementary Figure 1 from Therapeutic Effect of Lenalidomide in a Novel Xenograft Mouse Model of Human Blastic NK Cell Lymphoma/Blastic Plasmacytoid Dendritic Cell Neoplasm
Authors: Agliano Alice , Martin-Padura Ines , Marighetti Paola , Gregato Giuliana , Calleri Angelica , Prior Celia , Redrado Miriam , Calvo Alfonso , Bertolini Francesco
Published: April 2023

PDF file - 131KB
Supplementary Figure 1 from VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC
Authors: Lu Hailing , Dietsch Gregory N. , Matthews Maura-Ann H. , Yang Yi , Ghanekar Smita , Inokuma Margaret , Suni Maria , Maino Vernon C. , Henderson Katherine E. , Howbert James Jeffry , Disis Mary L. , Hershberg Robert M.
Published: April 2023

PDF file - 105K
Supplementary Figure 7 from Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor Markers
Authors: Reinert Thomas , Modin Charlotte , Castano Francisco M. , Lamy Philippe , Wojdacz Tomasz K. , Hansen Lise Lotte , Wiuf Carsten , Borre Michael , Dyrskjøt Lars , Ørntoft Torben F.
Published: April 2023

PDF file - 287K
Supplementary Table 5 from The Reconstruction of Transcriptional Networks Reveals Critical Genes with Implications for Clinical Outcome of Multiple Myeloma
Authors: Agnelli Luca , Forcato Mattia , Ferrari Francesco , Tuana Giacomo , Todoerti Katia , Walker Brian A. , Morgan Gareth J. , Lombardi Luigia , Bicciato Silvio , Neri Antonino
Published: April 2023

XLS file - 362K
Supplementary Figure 1 from The Reconstruction of Transcriptional Networks Reveals Critical Genes with Implications for Clinical Outcome of Multiple Myeloma
Authors: Agnelli Luca , Forcato Mattia , Ferrari Francesco , Tuana Giacomo , Todoerti Katia , Walker Brian A. , Morgan Gareth J. , Lombardi Luigia , Bicciato Silvio , Neri Antonino
Published: April 2023

PDF file - 175K
Supplementary Figure Legend 1, Tables 1-3 from Relationship between 18F-Fluorodeoxyglucose Accumulation and KRAS/BRAF Mutations in Colorectal Cancer
Authors: Kawada Kenji , Nakamoto Yuji , Kawada Mayumi , Hida Koya , Matsumoto Takuya , Murakami Teppei , Hasegawa Suguru , Togashi Kaori , Sakai Yoshiharu
Published: April 2023

PDF file - 97K
Supplementary Figure Legend from Increased TGF-α as a Mechanism of Acquired Resistance to the Anti-EGFR Inhibitor Cetuximab through EGFR–MET Interaction and Activation of MET Signaling in Colon Cancer Cells
Authors: Troiani Teresa , Martinelli Erika , Napolitano Stefania , Vitagliano Donata , Ciuffreda Loreta Pia , Costantino Sara , Morgillo Floriana , Capasso Anna , Sforza Vincenzo , Nappi Anna , De Palma Raffaele , D'Aiuto Elena , Berrino Liberato , Bianco Roberto , Ciardiello Fortunato
Published: April 2023

PDF file 84K, Supplementary figure legend
Supplementary Figure 3 from Tumor Stromal Architecture Can Define the Intrinsic Tumor Response to VEGF-Targeted Therapy
Authors: Smith Neil R. , Baker Dawn , Farren Matthew , Pommier Aurelien , Swann Ruth , Wang Xin , Mistry Sunita , McDaid Karen , Kendrew Jane , Womack Chris , Wedge Stephen R. , Barry Simon T.
Published: April 2023

PDF file - 260K, H+E comparison of typical morphologies of pancreatic neuroendocrine cancer and pancreatic adenocarcinoma and additional biomarker analyses of the two phenotypes.
Supplementary Figure 5 from Ontogeny and Sorafenib Metabolism
Authors: Zimmerman Eric I. , Roberts Justin L. , Li Lie , Finkelstein David , Gibson Alice , Chaudhry Amarjit S. , Schuetz Erin G. , Rubnitz Jeffrey E. , Inaba Hiroto , Baker Sharyn D.
Published: April 2023

PDF file, 63K, Age- and sex-dependent sorafenib glucuronide formation and correlation with UGT1A9 mRNA expression in human liver samples.
Supplementary Figure 2 from Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple Myeloma
Authors: Moschetta Michele , Basile Antonio , Ferrucci Arianna , Frassanito Maria Antonia , Rao Luigia , Ria Roberto , Solimando Antonio Giovanni , Giuliani Nicola , Boccarelli Angelina , Fumarola Fabio , Coluccia Mauro , Rossini Bernardo , Ruggieri Simona , Nico Beatrice , Maiorano Eugenio , Ribatti Domenico , Roccaro Aldo M. , Vacca Angelo
Published: April 2023

PDF file, 104K, Effect of SU11274 treatment on cMET/phospho(p)-cMET expression in R5 vs. RPMI8226 cells; and plasma cells (PCs) from relapsed/resistant vs. newly diagnosed MM patients.
Supplementary Table 3 from Clinical Significance and Prognostic Value of microRNA Expression Signatures in Hepatocellular Carcinoma
Authors: Wei Rongrong , Huang Guo-Liang , Zhang Mei-Yin , Li Bin-Kui , Zhang Hui-Zhong , Shi Ming , Chen Xiao-Qian , Huang Long , Zhou Qing-Ming , Jia Wei-Hua , Zheng X.F. Steven , Yuan Yun-Fei , Wang Hui-Yun
Published: April 2023

PDF file, 132K, Differential expression of miRNAs between clinical features.
Supplementary Table 2 from Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents
Authors: Mao Muling , Tian Feng , Mariadason John M. , Tsao Chun C. , Lemos Robert , Dayyani Farshid , Gopal Y.N. Vashisht , Jiang Zhi-Qin , Wistuba Ignacio I. , Tang Xi M. , Bornman William G. , Bollag Gideon , Mills Gordon B. , Powis Garth , Desai Jayesh , Gallick Gary E. , Davies Michael A. , Kopetz Scott
Published: April 2023

PDF file - 38K, KRAS, BRAF, PIK3CA, and PTEN status of utilized CRC cell lines.The mutation data was obtained from the Sanger Institute Catalogue Of Somatic Mutations In Cancer web site, http://www.sanger.ac.uk/cosmic. Bamford et al (2004) The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer, 91,355-358.
Supplementary Figure 5 from Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents
Authors: Mao Muling , Tian Feng , Mariadason John M. , Tsao Chun C. , Lemos Robert , Dayyani Farshid , Gopal Y.N. Vashisht , Jiang Zhi-Qin , Wistuba Ignacio I. , Tang Xi M. , Bornman William G. , Bollag Gideon , Mills Gordon B. , Powis Garth , Desai Jayesh , Gallick Gary E. , Davies Michael A. , Kopetz Scott
Published: April 2023

PDF file - 140K, HT29 and Colo205 parental and PLX-resistant (RC) cell lines were profiled by Affymetrix MIP array (OncoScan� FFPE Express 2.0 Services) for copy number. The following copy number plots were produced by Affymetrix Nexus CN 6.0. (build 6461). In the HT29 parental and HT29RC, the black arrows represent an increase in copy number in chromosome 7p acquired in the HT29RC. Similarly, in the Colo205RC, there is an acquired increase in copy number in chromosome 12p, denoted by the black arrow.
Supplementary Figure Legend from A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer
Authors: Berlin Jordan , Bendell Johanna C. , Hart Lowell L. , Firdaus Irfan , Gore Ira , Hermann Robert C. , Mulcahy Mary F. , Zalupski Mark M. , Mackey Howard M. , Yauch Robert L. , Graham Richard A. , Bray Gordon L. , Low Jennifer A.
Published: April 2023

PDF file - 61K
Supplementary Tables 1 - 10 from microRNA Expression Profiles Identify Subtypes of Mantle Cell Lymphoma with Different Clinicobiological Characteristics
Authors: Navarro Alba , Clot Guillem , Prieto Miriam , Royo Cristina , Vegliante Maria Carmela , Amador Virginia , Hartmann Elena , Salaverria Itziar , Beà Sílvia , Martín-Subero Jose Ignacio , Rosenwald Andreas , Ott German , Wiestner Adrian , Wilson Wyndham H. , Campo Elías , Hernández Luis
Published: April 2023

PDF file - 364K, Supplementary Table 1. Comparison of main features of MCL patients from the different studied series; Supplementary Table 2. Normalized expression in miRs with SD variation higher than 50th percentile and detectable expression >25% of cases; Supplementary Table 3a. Subgroups of leukemic MCL according IGHV status and core miR expression clusters and related data; Supplementary Table 3b. Additional data in leukemic MCL with studied mRNA by arrays; Supplementary Table 4a. Results of supervised Limma analysis between Unmutated vs Mutated IGHV MCL; Supplementary Table 4b. Results of supervised Limma analysis between High vs Low SOX11 expressing MCL; Supplementary Table 5a. Overlapping of miR lists from Venn diagram (Supplementary Figure 2); Supplementary Table 5b. Results of supervised Limma analysis between the different MCL subgroups; Supplementary Table 6a. miR expression fold changes for IGHV mutational status in the 16 MCL series compared to the whole sample set; Supplementary Table 6b. Expression fold changes between IGHV mutational status categories in the 16 MCL series for those genes predicted to be targets for IGHV-related miRs and involved in significant enriched pathways; Supplementary Table 7a. MAGIA output for inverse Spearman correlation between IGHV-related miRs and mRNA expression values in 16 leukemic MCL; Supplementary Table 7b. Significant results from GSEA analysis from pre-ranked list of correlations between IGHV-related miRs and their putative targets; Supplementary Table 7c. Gene lists from significant GSEA analysis results from pre-ranked list of correlations between IGHV-related miRs and their putative targets; Supplementary Table 8a. MAGIA output for inverse Spearman correlation between miR-708 and miR-455-5p/3p and mRNA expression values in 16 leukemic MCL; Supplementary Table 8b. Enrichment analysis (g:Profiler) significant results from inversely correlated predicted targets for miR-708 and miR-455-5p/3p (top 75% subset); Supplementary Table 9. Proliferation signature calculations in the 16 leukemic MCL with gene expression data; Supplementary Table 10. Correlation analysis of miR expression and MCL proliferation signature.
Supplementary Figures 1 - 7 from microRNA Expression Profiles Identify Subtypes of Mantle Cell Lymphoma with Different Clinicobiological Characteristics
Authors: Navarro Alba , Clot Guillem , Prieto Miriam , Royo Cristina , Vegliante Maria Carmela , Amador Virginia , Hartmann Elena , Salaverria Itziar , Beà Sílvia , Martín-Subero Jose Ignacio , Rosenwald Andreas , Ott German , Wiestner Adrian , Wilson Wyndham H. , Campo Elías , Hernández Luis
Published: April 2023

PDF file - 471K, Supplementary Figure 1. Consensus clustering analysis from miR expression profiling data obtained using qRT-PCR in the whole 30 leukemic MCL series; Supplementary Figure 2. Venn diagram of overlapping significant differentially expressed miRs between subgroups with different IGHV status among the core clusters (as defined in Supplementary Table 3); Supplementary Figure 3. Plots of the significant enrichment profiles showing the distribution of the top significant gene sets identified in the GSEA analysis for the inversely correlated predicted targets of the miRs differentially expressed regarding IGHV mutational status categories; Supplementary Figure 4. Correlation plots between the expression levels measured by qRT-PCR of miR-455-5p/miR-708 and their putative targets corresponding to histone methylation transferases, and that were previously found correlated in leukemic MCL with microarray gene expression data; Supplementary Figure 5. Overall survival of the 30 leukemic MCL patients according to IGHV status (A) and SOX11 expression level (B); Supplementary Figure 6. Overall survival of the 30 leukemic MCL patients according to IGHV status (A) and SOX11 expression level (B) in combination with miR-34a expression level; Supplementary Figure 7. Overall survival of the validation series of 29 MCL patients according to miR-34a expression level.
Supplementary Table 2 from Individual Patient-Specific Immunity against High-Grade Glioma after Vaccination with Autologous Tumor Derived Peptides Bound to the 96 KD Chaperone Protein
Authors: Crane Courtney A. , Han Seunggu J. , Ahn Brian , Oehlke Jessica , Kivett Valerie , Fedoroff Anne , Butowski Nicholas , Chang Susan M. , Clarke Jennifer , Berger Mitchel S. , McDermott Michael W. , Prados Michael D. , Parsa Andrew T.
Published: April 2023

PDF file, 29K, Vaccine Administration Schedule and Characteristics of Adverse Events.
Supplementary Table 3 from Prolonged Postovulatory Proinflammatory Signaling in the Fallopian Tube Epithelium May Be Mediated through a BRCA1/DAB2 Axis
Authors: Tone Alicia A. , Virtanen Carl , Shaw Patricia , Brown Theodore J.
Published: April 2023

PDF file, 59K, NFκB-regulated and inflammation-related genes differentially expressed in FTEb(S) samples (n=4) relative to remaining luteal phase FTE samples (n=8).